Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Pascal, Claudepierre"'
Autor:
Jérémie Sellam, Laure Gossec, Pascal Claudepierre, Axel Finckh, Grégoire Cormier, Renaud Felten, Emmanuelle Dernis, Arnaud Constantin, Hubert Marotte, Philippe Goupille, Thierry Schaeverbeke, Athan Baillet, Anne Tournadre, Tristan Pascart, Maxime Breban, Valerie Devauchelle, Thierry Lequerre, Christian Jorgensen, Eric Lespessailles, Elisabeth Gervais, Daniel Wendling, Cédric Lukas, Corinne Miceli, Emilie Presles, Stephan Pavy, Jean-Hugues Salmon, Christian Marcelli, Olivier Brocq, Beatrice Bouvard, Benoit Le Goff, Florence Rancon, Theodora Bejan-Angoulvant, Elisa Dalix, Madjid Akrour, Liliane De Araujo, Christian H Roux
Publikováno v:
BMJ Open, Vol 14, Iss 9 (2024)
Introduction Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterised by inflammatory low back pain. Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended as a first treatment in axSpA. In case of inadequate response t
Externí odkaz:
https://doaj.org/article/7b09aa494dc5437db5fef56602eb6bc8
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objectives To assess the potential impact of targeted therapies for psoriatic arthritis (PsA) on symptomatic treatments (non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, opioid analgesics), methotrexate and mood disorder treatments an
Externí odkaz:
https://doaj.org/article/48246494375a46bd91271bfde4d743a2
Autor:
Francis Berenbaum, Maxime Dougados, Laure Gossec, Anna Molto, Pascal Claudepierre, Adeline Ruyssen-Witrand, Bernard Combe, Alain Saraux, Chris Serrand, Thierry Lequerre, Daniel Wendling, Sandrine Alonso
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Background Inception cohorts aim to describe chronic diseases from diagnosis and over years of follow-up. Axial spondyloarthritis (axSpA) diagnosis might be challenging during the first years of the disease. Thus, identifying the features that will b
Externí odkaz:
https://doaj.org/article/e749d87d497e46258b65193e2473fdb9
Autor:
Léa Hoisnard, Bénédicte Lebrun-Vignes, Sébastien Maury, Matthieu Mahevas, Khalil El Karoui, Lydia Roy, Anissa Zarour, Marc Michel, José L. Cohen, Aurélien Amiot, Pascal Claudepierre, Pierre Wolkenstein, Philippe Grimbert, Emilie Sbidian
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Increasing number of Janus kinase (JAK) inhibitors have been approved for chronic haematopoietic neoplasms and inflammatory/autoimmune diseases. We aimed to assess safety of the first three approved JAK inhibitors: ruxolitinib, tofacitinib a
Externí odkaz:
https://doaj.org/article/2ca98a65657442a48f5704f32414808b
Autor:
Maxime Dougados, Pascal Claudepierre, Adeline Ruyssen-Witrand, Philippe Goupille, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas, Julien Lucas, Emilie Desfleurs
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Background Secukinumab efficacy and retention data are emerging in patients with axial spondyloarthritis (axSpA) in real-world settings. However, limited data are available on the predictive factors that affect the retention rate. The key objective w
Externí odkaz:
https://doaj.org/article/ae96de24f6f547aca327e1b2f0754cca
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Introduction Tumour necrosis factor inhibitor (TNFi) agents are most often the first-choice biological treatment for patients with psoriatic arthritis (PsA). When their discontinuation is needed, a switch to another TNFi or to another therapeutic cla
Externí odkaz:
https://doaj.org/article/41fc3a56585b4511a4df1e396eb522ab
Autor:
Walter P. Maksymowych, Pascal Claudepierre, Manouk de Hooge, Robert G. Lambert, Robert Landewé, Anna Molto, Désirée van der Heijde, Jack F. Bukowski, Heather Jones, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Maxime Dougados
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-14 (2021)
Abstract Background Limited information is available on the impact of treatment with a tumor necrosis factor inhibitor (TNFi) on structural lesions in patients with recent-onset axial spondyloarthritis (axSpA). We compared 2-year structural lesion ch
Externí odkaz:
https://doaj.org/article/907b9f77ff8d48f985da26d6f8f858f6
Autor:
Maxime Dougados, Pascal Claudepierre, Adeline Ruyssen-Witrand, Philippe Goupille, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas, Julien Lucas, Emilie Desfleurs
Publikováno v:
RMD Open, Vol 8, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/2169180aef9e416a83daa96d1e1dddfd
Autor:
Adeline Ruyssen-Witrand, Cécile Luxembourger, Alain Cantagrel, Delphine Nigon, Pascal Claudepierre, Yannick Degboe, Arnaud Constantin
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-8 (2019)
Abstract Background To investigate the association between 12 single nucleotide polymorphisms (SNPs) located on ERAP1 and IL23R with the presence of inflammation on the sacroiliac joint (SIJ) or spinal magnetic resonance imagery (MRI) in an early ons
Externí odkaz:
https://doaj.org/article/5bdc039d6c874e71aa84f04198847e69
Autor:
Daniel Wendling, Frank Verhoeven, Pascal Claudepierre, Philippe Goupille, Thao Pham, Clément Prati
Publikováno v:
Revue du Rhumatisme. 89:538-541